July 29, 2025

Postpartum Pelvic Floor Disorders Often Overlooked, Review Finds

Emerging diagnostic tools such as dynamic ultrasound and anorectal manometry offer clinicians improved evaluation of postpartum pelvic floor disorders, yet standardized screening protocols remain limited.

Conexiant

July 23, 2025

IDSA Issues Stratified Antibiotic Approach for complicated UTIs

New recommendations outline a stratified antibiotic treatment for complicated urinary tract infections, including shorter durations, oral transition timing, and tailored empiric choices based on illness severity and resistance risks.

Conexiant

July 22, 2025

Placenta Accreta Guidelines Lack Consensus: Review

A new review of clinical guidelines highlights consistent recommendations for diagnosing and managing placenta accreta spectrum disorders, but showed gaps in guidance for surgery, fertility counseling, and postnatal care, especially in low-resource settings.

Conexiant

July 14, 2025

Prostate Cancer Risks Shift in PSA Era

New research in Sweden reveals that obesity and smoking were linked to fewer diagnoses of non-aggressive prostate cancer, likely due to lower PSA screening uptake, while height remained consistently associated with higher prostate cancer risk.

Conexiant

July 02, 2025

Social Media Fuels Confusion Around Vasectomy Trends

A new review highlights how social media is shaping perceptions of vasectomy, with persistent misinformation, cultural stigma, and rising demand in the wake of the Dobbs ruling influencing men’s health decisions.

Conexiant

April 29, 2025

Foley Catheter Management: New Best Practices, Pitfalls

Foley catheter use is associated with a wide range of complications, from infections to urethral erosion.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 09, 2025

Which Treatment Works Best for Mixed Incontinence?

New clinical trial finds no significant difference between onabotulinumtoxinA and midurethral sling for mixed urinary incontinence at 6 months.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant